SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- Cancer
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: russet who wrote (1797)12/30/2013 6:52:28 PM
From: N. Dixon   of 1840
 
I am watching this discussed on News Hour right now. Here's an article I found on tests in animals. Looks very promising. I have a friend who had Stage 4 melanoma and was in a trial for Interferon and her cancer went into remission.

The small trials have been with melanoma, pancreatic cancer, leukemia and they've been able to augment the immune system and tweak the cells so they only go after the cancer cells and not attack all the cells in the body. They also discussed how the monies are drying up for this research in Washington. I hope we can get more federal funding for this. The big pharmas have not been involved in this. The sequester had a direct affect on their budget to further this research. I think we should let our congresspeople know that this is something we want to see funded. These studies are in the very early stages but they feel this is a very promising treatment to explore.

Having pancreatic cancer in my family, I know how difficult early diagnosis is and so this is welcome news.

I
I mmune Systems to Attack Tumors

ND
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News